tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

UNCY Stock Latest News

Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?
Market NewsWhy Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?
36m ago
UNCY
Buy Rating for Unicycive Therapeutics: Strong Market Potential Despite Vendor Compliance Issue
PremiumRatings
Buy Rating for Unicycive Therapeutics: Strong Market Potential Despite Vendor Compliance Issue
42m ago
UNCY
Unicycive Therapeutics Faces FDA Compliance Delay
PremiumCompany Announcements
Unicycive Therapeutics Faces FDA Compliance Delay
43m ago
8K
UNCY
Unicycive Therapeutics provides update on NDA for oxylanthanum carbonate
PremiumThe Fly
Unicycive Therapeutics provides update on NDA for oxylanthanum carbonate
4h ago
UNCY
Unicycive Therapeutics initiated with a Buy at Lucid Capital
PremiumThe Fly
Unicycive Therapeutics initiated with a Buy at Lucid Capital
6d ago
UNCY
Buy Rating for Unicycive Therapeutics: Innovative Approach to Hyperphosphatemia Treatment with Oxylanthanum Carbonate
PremiumRatingsBuy Rating for Unicycive Therapeutics: Innovative Approach to Hyperphosphatemia Treatment with Oxylanthanum Carbonate
12d ago
UNCY
Unicycive Therapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
Unicycive Therapeutics assumed with a Buy at H.C. Wainwright
14d ago
UNCY
Unicycive Therapeutics Updates Annual Meeting Time
Premium
Company Announcements
Unicycive Therapeutics Updates Annual Meeting Time
20d ago
8K
UNCY
Unicycive Therapeutics announces time change for FY25 annual meeting
PremiumThe Fly
Unicycive Therapeutics announces time change for FY25 annual meeting
20d ago
UNCY
Buy Rating for Unicycive Therapeutics Driven by Strategic Positioning and Upcoming Regulatory Milestones
PremiumRatings
Buy Rating for Unicycive Therapeutics Driven by Strategic Positioning and Upcoming Regulatory Milestones
24d ago
UNCY
Unicycive Therapeutics reports Q1 EPS (5c), consensus (6c)
PremiumThe Fly
Unicycive Therapeutics reports Q1 EPS (5c), consensus (6c)
27d ago
UNCY
Unicycive Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
Unicycive Therapeutics initiated with a Buy at Guggenheim
2M ago
UNCY
Buy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment
PremiumRatingsBuy Rating for Unicycive Therapeutics: Competitive Advantages of Oxylanthanum Carbonate in Hyperphosphatemia Treatment
2M ago
UNCY
Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate
Premium
Ratings
Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate
2M ago
UNCY
Unicycive presents new patient-level data from Phase 2 study of OLC
Premium
The Fly
Unicycive presents new patient-level data from Phase 2 study of OLC
2M ago
UNCY
Buy Rating for Unicycive Therapeutics Amid Favorable Risk/Reward and Strategic Growth Opportunities
PremiumRatings
Buy Rating for Unicycive Therapeutics Amid Favorable Risk/Reward and Strategic Growth Opportunities
2M ago
UNCY
Promising Prospects for Unicycive Therapeutics: Buy Rating Backed by Upcoming Milestones and Strategic Preparations
PremiumRatings
Promising Prospects for Unicycive Therapeutics: Buy Rating Backed by Upcoming Milestones and Strategic Preparations
2M ago
UNCY
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
2M ago
UNCY
Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)
PremiumThe Fly
Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)
2M ago
UNCY
Is UNCY a Buy, Before Earnings?
PremiumPre-EarningsIs UNCY a Buy, Before Earnings?
3M ago
UNCY
Unicycive to present patient reported outcomes data from UNI-OLC-201 study
Premium
The Fly
Unicycive to present patient reported outcomes data from UNI-OLC-201 study
3M ago
UNCY
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
Premium
The Fly
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
4M ago
UNCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >